IntelligentCare: Wearable-based Intervention
Launched by GLSMED LEARNING HEALTH S.A. · Mar 17, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The IntelligentCare trial is studying how using a smartwatch can help older adults with multiple health conditions improve their physical activity and sleep quality. The researchers believe that by encouraging more movement and better sleep through a wearable device, they can help these individuals manage their health without relying solely on medication. To participate, people need to be over 65 years old, have at least two chronic health issues (like high blood pressure, diabetes, or arthritis), and have access to a smartphone.
Participants will receive special content on how to be more active and will be randomly assigned to wear a smartwatch that tracks their activity. The main goal is to see how much their physical activity improves after six months. Additionally, the study will look at other benefits, like changes in overall health, quality of life, and any hospital visits. This research aims to provide valuable insights into how technology can support healthier lifestyles in older adults facing multiple health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Multimorbidity defined as the presence of two or more of the following chronic conditions: hypertension, depression or anxiety, chronic musculoskeletal conditions causing pain or limitation, arthritis and/or rheumatoid arthritis, osteoporosis, asthma, COPD, ischemic heart disease, peripheral artery disease, heart failure, cerebrovascular diseases, chronic stomach or colon conditions, chronic hepatitis, diabetes mellitus, thyroid disorders, any active cancer in the previous five years, chronic kidney disease, chronic urinary conditions, hyperlipidemia, and obesity
- • Must have access to their smartphones
- Exclusion Criteria:
- • patients who are sufficiently physically active (IPAQ-SF \> 150 min aerobic physical activity per week)
- • existing absolute contraindication for PA according to the American College of Sports Medicine (acute myocardial infarction within two days, ongoing unstable angina, uncontrolled cardiac arrhythmia with hemodynamic compromise, active endocarditis, symptomatic severe aortic stenosis, decompensated heart failure, acute pulmonary embolism, pulmonary infarction, deep venous thrombosis, acute myocarditis or pericarditis, acute aortic dissection, physical disability that precludes safe and adequate testing)
- • poor comprehension of Portuguese language
- • disabling neurological disorder (defined as mRankin score ≥4), severe psychiatric illness, learning disability, dementia and cognitive impairment, registered blind
- • housebound or resident in a nursing home or non-ambulant
- • advanced cancer
- • scheduled for surgery within five months after the first consultation
- • orthopedic or rheumatologic diseases with severe impairment
- • chronic pain syndromes with inherently reduced mobility
About Glsmed Learning Health S.A.
Glsmed Learning Health S.A. is a pioneering clinical trial sponsor dedicated to advancing medical research through innovative learning health systems. Committed to improving patient outcomes, Glsmed leverages cutting-edge technology and data analytics to design, implement, and oversee clinical trials that are both efficient and ethically sound. With a focus on collaboration and transparency, Glsmed partners with healthcare providers, researchers, and regulatory bodies to ensure the highest standards of scientific rigor and safety in all of its studies, ultimately contributing to the rapid translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lisboa, , Portugal
Patients applied
Trial Officials
Bernardo Neves, MD
Principal Investigator
Researcher
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials